Research peptides are short chains of amino acids sold primarily by vendors like a peptide supplier for research use marketed for laboratory investigation rather than human consumption. Despite that labeling, many buyers are biohackers, athletes, or individuals seeking alternatives to prescription therapies, drawn by claims of muscle growth, fat loss, anti-aging effects, and cognitive enhancement. In Canada and most jurisdictions, these compounds occupy a legal gray zone: they’re not approved drugs, yet selling them “for research only” sidesteps therapeutic goods regulation, leaving…
Category: Law, Policy & Access
Authoritative guides to the legal status, regulation, and real‑world access pathways for psychedelics, cannabis, and functional mushrooms—covering regional laws, clinical frameworks, decriminalization/legalization updates, insurance, and patient eligibility.
Authoritative guides to the legal status, regulation, and real‑world access pathways for psychedelics, cannabis, and functional mushrooms—covering regional laws, clinical frameworks, decriminalization/legalization updates, insurance, and patient eligibility.
